Five Things You Need to Know About the Biopharmaceutical Research Ecosystem During COVID-19

A teaser image featuring the first page of the a recent PhRMA report, reading "Five Things You Need to Know About the Biopharmaceutical Research Ecosystem During COVID-19"

America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world.

A teaser image featuring the first page of the a recent PhRMA report, reading "Five Things You Need to Know About the Biopharmaceutical Research Ecosystem During COVID-19"

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.